Pharmacosmos was established in 1965 by Henry Christensen MD, PhD, who was succeeded by his youngest son Lars Christensen, MD, as CEO in 1993. The company has since its establishment remained an independent family owned company.
The first 500 m2 manufacturing site - site Viby - was established in 1965 in a former dairy in a small village about 40 kilometres from the current site Holbaek. The original manufacturing site was expanded to approximately 1800 m2 in 1973.
Originally, the company was an API manufacturer of dextran powder of clinical grade, pharmacopoeial quality for production of infusion solutions and iron complexes. The API was and is still available in powder and/or bulk solutions for the manufacturing of veterinary iron dextran injection.
The company gained GMP approval from Danish Ministry of Health early-on, followed by a number of US FDA approvals after a 1983 US FDA inspection carried out by Mr Charles A. Wayne.
In 2011, Pharmacosmos established Pharmacosmos UK, its fully-owned subsidiary, with its head office in Reading, to market and distribute its products for the treatment of iron deficiency in the United Kingdom and Republic of Ireland.
Click here to see the Interactive Pharmacosmos timeline